Seegene, Inc. (KOSDAQ:096530)

Market Cap	1.54T +28.4%
Revenue (ttm)	509.27B +12.1%
Net Income	91.74B
EPS	1,998.06
Shares Out	45.56M
PE Ratio	16.94
Forward PE	16.41
Dividend	1,000.00 (2.95%)
Ex-Dividend Date	Jun 29, 2026

Volume	212,598
Open	33,950
Previous Close	34,450
Day's Range	33,200 - 34,250
52-Week Range	21,700 - 40,450
Beta	0.90
Analysts	Buy
Price Target	48,000.00 (+41.8%)
Est. Earnings	Nov 6, 2026

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 761
• Stock Exchange: KOSDAQ
• Ticker Symbol: 096530

Analyst Summary

According to 2 analysts, the average rating for 096530 stock is "Buy." The 12-month stock price target is ₩48,000, which is an increase of 41.80% from the latest price.

Price Target

₩48,000

(41.80% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error